Selected research
Industry Research
I.V. (Intravenous Fluid) Bags Industry Research Report 2026
Market perspective
The global I.V. (Intravenous Fluid) Bags market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for I.V. (Intravenous Fluid) Bags is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for I.V. (Intravenous Fluid) Bags is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for I.V. (Intravenous Fluid) Bags is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of I.V. (Intravenous Fluid) Bags include Amcor, Baxter, Fresenius Kabi, Hospira (Pfizer), ICU Medical, Inc., JW Lifescience Corporation, Otsuka Pharmaceutical, SIPPEX and Wihuri Group, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global I.V. (Intravenous Fluid) Bags market in terms of revenue (US$ million) and, where applicable, sales volume (Units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/Units) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
I.V. (Intravenous Fluid) Bags Market by Company
Amcor
Baxter
Fresenius Kabi
Hospira (Pfizer)
ICU Medical, Inc.
JW Lifescience Corporation
Otsuka Pharmaceutical
SIPPEX
Wihuri Group
B. Braun
I.V. (Intravenous Fluid) Bags Segment by Type
Polyolefin IV Bags
PVC (polyvinyl chloride) IV Bags
Others
I.V. (Intravenous Fluid) Bags Segment by Application
Veterinary Medicine
Drug Delivery
Healthcare
I.V. (Intravenous Fluid) Bags Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global I.V. (Intravenous Fluid) Bags market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of I.V. (Intravenous Fluid) Bags and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of I.V. (Intravenous Fluid) Bags.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of I.V. (Intravenous Fluid) Bags manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of I.V. (Intravenous Fluid) Bags by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of I.V. (Intravenous Fluid) Bags in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Polyolefin IV Bags
- PVC (polyvinyl chloride) IV Bags
- Others
Applications
- Veterinary Medicine
- Drug Delivery
- Healthcare
Companies covered
- Amcor
- Baxter
- Fresenius Kabi
- Hospira (Pfizer)
- ICU Medical, Inc.
- JW Lifescience Corporation
- Otsuka Pharmaceutical
- SIPPEX
- Wihuri Group
- B. Braun
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global I.V. (Intravenous Fluid) Bags Market Size (2021-2032)
- 2.2.2 Global I.V. (Intravenous Fluid) Bags Sales (2021-2032)
- 2.2.3 Global I.V. (Intravenous Fluid) Bags Market Average Price (2021-2032)
- 2.3 I.V. (Intravenous Fluid) Bags by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Polyolefin IV Bags
- 2.3.3 PVC (polyvinyl chloride) IV Bags
- 2.3.4 Others
- 2.4 I.V. (Intravenous Fluid) Bags by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Veterinary Medicine
- 2.4.3 Drug Delivery
- 2.4.4 Healthcare
3 Market Competitive Landscape by Manufacturers
- 3.1 Global I.V. (Intravenous Fluid) Bags Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global I.V. (Intravenous Fluid) Bags Sales (Units) of Manufacturers (2021-2026)
- 3.3 Global I.V. (Intravenous Fluid) Bags Revenue of Manufacturers (2021-2026)
- 3.4 Global I.V. (Intravenous Fluid) Bags Average Price by Manufacturers (2021-2026)
- 3.5 Global I.V. (Intravenous Fluid) Bags Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of I.V. (Intravenous Fluid) Bags, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of I.V. (Intravenous Fluid) Bags, Product Type & Application
- 3.8 Global Manufacturers of I.V. (Intravenous Fluid) Bags, Established Date
- 3.9 Global I.V. (Intravenous Fluid) Bags Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Amcor
- 4.1.1 Amcor Company Information
- 4.1.2 Amcor Business Overview
- 4.1.3 Amcor I.V. (Intravenous Fluid) Bags Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Amcor I.V. (Intravenous Fluid) Bags Product Portfolio
- 4.1.5 Amcor Recent Developments
- 4.2 Baxter
- 4.2.1 Baxter Company Information
- 4.2.2 Baxter Business Overview
- 4.2.3 Baxter I.V. (Intravenous Fluid) Bags Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Baxter I.V. (Intravenous Fluid) Bags Product Portfolio
- 4.2.5 Baxter Recent Developments
- 4.3 Fresenius Kabi
- 4.3.1 Fresenius Kabi Company Information
- 4.3.2 Fresenius Kabi Business Overview
- 4.3.3 Fresenius Kabi I.V. (Intravenous Fluid) Bags Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Fresenius Kabi I.V. (Intravenous Fluid) Bags Product Portfolio
- 4.3.5 Fresenius Kabi Recent Developments
- 4.4 Hospira (Pfizer)
- 4.4.1 Hospira (Pfizer) Company Information
- 4.4.2 Hospira (Pfizer) Business Overview
- 4.4.3 Hospira (Pfizer) I.V. (Intravenous Fluid) Bags Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Hospira (Pfizer) I.V. (Intravenous Fluid) Bags Product Portfolio
- 4.4.5 Hospira (Pfizer) Recent Developments
- 4.5 ICU Medical, Inc.
- 4.5.1 ICU Medical, Inc. Company Information
- 4.5.2 ICU Medical, Inc. Business Overview
- 4.5.3 ICU Medical, Inc. I.V. (Intravenous Fluid) Bags Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 ICU Medical, Inc. I.V. (Intravenous Fluid) Bags Product Portfolio
- 4.5.5 ICU Medical, Inc. Recent Developments
- 4.6 JW Lifescience Corporation
- 4.6.1 JW Lifescience Corporation Company Information
- 4.6.2 JW Lifescience Corporation Business Overview
- 4.6.3 JW Lifescience Corporation I.V. (Intravenous Fluid) Bags Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 JW Lifescience Corporation I.V. (Intravenous Fluid) Bags Product Portfolio
- 4.6.5 JW Lifescience Corporation Recent Developments
- 4.7 Otsuka Pharmaceutical
- 4.7.1 Otsuka Pharmaceutical Company Information
- 4.7.2 Otsuka Pharmaceutical Business Overview
- 4.7.3 Otsuka Pharmaceutical I.V. (Intravenous Fluid) Bags Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 Otsuka Pharmaceutical I.V. (Intravenous Fluid) Bags Product Portfolio
- 4.7.5 Otsuka Pharmaceutical Recent Developments
- 4.8 SIPPEX
- 4.8.1 SIPPEX Company Information
- 4.8.2 SIPPEX Business Overview
- 4.8.3 SIPPEX I.V. (Intravenous Fluid) Bags Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 SIPPEX I.V. (Intravenous Fluid) Bags Product Portfolio
- 4.8.5 SIPPEX Recent Developments
- 4.9 Wihuri Group
- 4.9.1 Wihuri Group Company Information
- 4.9.2 Wihuri Group Business Overview
- 4.9.3 Wihuri Group I.V. (Intravenous Fluid) Bags Sales, Revenue and Gross Margin (2021-2026)
- 4.9.4 Wihuri Group I.V. (Intravenous Fluid) Bags Product Portfolio
- 4.9.5 Wihuri Group Recent Developments
- 4.10 B. Braun
- 4.10.1 B. Braun Company Information
- 4.10.2 B. Braun Business Overview
- 4.10.3 B. Braun I.V. (Intravenous Fluid) Bags Sales, Revenue and Gross Margin (2021-2026)
- 4.10.4 B. Braun I.V. (Intravenous Fluid) Bags Product Portfolio
- 4.10.5 B. Braun Recent Developments
5 Global I.V. (Intravenous Fluid) Bags Market Scenario by Region
- 5.1 Global I.V. (Intravenous Fluid) Bags Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global I.V. (Intravenous Fluid) Bags Sales by Region: 2021-2032
- 5.2.1 Global I.V. (Intravenous Fluid) Bags Sales by Region: 2021-2026
- 5.2.2 Global I.V. (Intravenous Fluid) Bags Sales by Region: 2027-2032
- 5.3 Global I.V. (Intravenous Fluid) Bags Revenue by Region: 2021-2032
- 5.3.1 Global I.V. (Intravenous Fluid) Bags Revenue by Region: 2021-2026
- 5.3.2 Global I.V. (Intravenous Fluid) Bags Revenue by Region: 2027-2032
- 5.4 North America I.V. (Intravenous Fluid) Bags Market Facts & Figures by Country
- 5.4.1 North America I.V. (Intravenous Fluid) Bags Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America I.V. (Intravenous Fluid) Bags Sales by Country (2021-2032)
- 5.4.3 North America I.V. (Intravenous Fluid) Bags Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.4.6 Mexico
- 5.5 Europe I.V. (Intravenous Fluid) Bags Market Facts & Figures by Country
- 5.5.1 Europe I.V. (Intravenous Fluid) Bags Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe I.V. (Intravenous Fluid) Bags Sales by Country (2021-2032)
- 5.5.3 Europe I.V. (Intravenous Fluid) Bags Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Russia
- 5.5.9 Spain
- 5.5.10 Netherlands
- 5.5.11 Switzerland
- 5.5.12 Sweden
- 5.5.13 Poland
- 5.6 Asia Pacific I.V. (Intravenous Fluid) Bags Market Facts & Figures by Country
- 5.6.1 Asia Pacific I.V. (Intravenous Fluid) Bags Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific I.V. (Intravenous Fluid) Bags Sales by Country (2021-2032)
- 5.6.3 Asia Pacific I.V. (Intravenous Fluid) Bags Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America I.V. (Intravenous Fluid) Bags Market Facts & Figures by Country
- 5.7.1 South America I.V. (Intravenous Fluid) Bags Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America I.V. (Intravenous Fluid) Bags Sales by Country (2021-2032)
- 5.7.3 South America I.V. (Intravenous Fluid) Bags Revenue by Country (2021-2032)
- 5.7.4 Brazil
- 5.7.5 Argentina
- 5.7.6 Chile
- 5.8 Middle East and Africa I.V. (Intravenous Fluid) Bags Market Facts & Figures by Country
- 5.8.1 Middle East and Africa I.V. (Intravenous Fluid) Bags Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa I.V. (Intravenous Fluid) Bags Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa I.V. (Intravenous Fluid) Bags Revenue by Country (2021-2032)
- 5.8.4 Egypt
- 5.8.5 South Africa
- 5.8.6 Israel
- 5.8.7 Türkiye
- 5.8.8 GCC Countries
6 Segment by Type
- 6.1 Global I.V. (Intravenous Fluid) Bags Sales by Type (2021-2032)
- 6.1.1 Global I.V. (Intravenous Fluid) Bags Sales by Type (2021-2032) & (Units)
- 6.1.2 Global I.V. (Intravenous Fluid) Bags Sales Market Share by Type (2021-2032)
- 6.2 Global I.V. (Intravenous Fluid) Bags Revenue by Type (2021-2032)
- 6.2.1 Global I.V. (Intravenous Fluid) Bags Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global I.V. (Intravenous Fluid) Bags Revenue Market Share by Type (2021-2032)
- 6.3 Global I.V. (Intravenous Fluid) Bags Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global I.V. (Intravenous Fluid) Bags Sales by Application (2021-2032)
- 7.1.1 Global I.V. (Intravenous Fluid) Bags Sales by Application (2021-2032) & (Units)
- 7.1.2 Global I.V. (Intravenous Fluid) Bags Sales Market Share by Application (2021-2032)
- 7.2 Global I.V. (Intravenous Fluid) Bags Revenue by Application (2021-2032)
- 7.2.1 Global I.V. (Intravenous Fluid) Bags Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global I.V. (Intravenous Fluid) Bags Revenue Market Share by Application (2021-2032)
- 7.3 Global I.V. (Intravenous Fluid) Bags Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 I.V. (Intravenous Fluid) Bags Value Chain Analysis
- 8.1.1 I.V. (Intravenous Fluid) Bags Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 I.V. (Intravenous Fluid) Bags Production Mode & Process
- 8.2 I.V. (Intravenous Fluid) Bags Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 I.V. (Intravenous Fluid) Bags Distributors
- 8.2.3 I.V. (Intravenous Fluid) Bags Customers
9 Global I.V. (Intravenous Fluid) Bags Analyzing Market Dynamics
- 9.1 I.V. (Intravenous Fluid) Bags Industry Trends
- 9.2 I.V. (Intravenous Fluid) Bags Industry Drivers
- 9.3 I.V. (Intravenous Fluid) Bags Industry Opportunities and Challenges
- 9.4 I.V. (Intravenous Fluid) Bags Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst